What is FOLFIRINOX?
FOLFIRINOX is a combination chemotherapy regimen used mainly to treat pancreatic cancer. It combines four medicines, and its name is built from parts of their names:
| Part of name | Medicine | Type |
|---|---|---|
| FOL | Folinic acid (leucovorin) | Vitamin that boosts the effect of fluorouracil |
| F | Fluorouracil (5-FU) | Antimetabolite chemotherapy |
| IRIN | Irinotecan | Topoisomerase I inhibitor |
| OX | Oxaliplatin | Platinum chemotherapy |
FOLFIRINOX is given every two weeks. On treatment day, three of the drugs are given by drip in hospital, and then fluorouracil runs slowly over about 46 hours through a small portable pump that you take home. Most people now receive a modified version (mFOLFIRINOX), which leaves out the initial quick injection of fluorouracil and may use a lower irinotecan dose to reduce side effects.
It is one of the most effective chemotherapy regimens available for pancreatic cancer, but it is also demanding. It is generally offered to people who are fairly fit and able to manage the side effects.
A brief history
For many years, gemcitabine alone was the standard chemotherapy for advanced pancreatic cancer, offering only modest benefit. French researchers combined the drugs that make up FOLFIRINOX in the early 2000s, and a large trial published in 2011 showed it clearly outperformed gemcitabine. A later trial showed that a modified version given after surgery helped people live substantially longer, making it a standard choice in that setting as well.
1. Key facts at a glance
| Feature | Details |
|---|---|
| Type of treatment | Combination chemotherapy |
| Main use | Pancreatic cancer: after surgery, before surgery, and for advanced disease |
| How it is given | Drip on day 1, then a 46-hour fluorouracil pump at home |
| Cycle length | Every 14 days |
| Usual course | 12 cycles (about 6 months) after surgery; as long as it helps for advanced cancer |
| Who it suits | People who are fit enough for intensive chemotherapy |
| Main side effects | Tiredness, diarrhoea, nausea, low blood counts, nerve damage in hands and feet |
2. How it works
| Medicine | How it acts |
|---|---|
| Fluorouracil | Blocks an enzyme needed to make DNA, starving cancer cells of building blocks |
| Folinic acid | Helps fluorouracil bind more tightly to its target enzyme |
| Irinotecan | Blocks topoisomerase I, an enzyme that untangles DNA during copying |
| Oxaliplatin | Forms cross-links within DNA, stopping cells dividing |
By attacking cancer cells through several different routes at once, the combination is more effective than any single drug. Pancreatic cancer is notoriously resistant to treatment, so this broad attack is particularly valuable.
Why the 46-hour pump?
Fluorouracil breaks down quickly in the body. Giving it slowly over two days keeps a steady level in the blood, which improves its effect and reduces some side effects. The pump is small, usually carried in a bag or belt pouch, and connected to a central line such as a PICC line or port.
3. Who it is for
Conditions treated
| Condition | Role of FOLFIRINOX |
|---|---|
| Pancreatic ductal adenocarcinoma | After surgery, before surgery, for locally advanced and for metastatic disease |
| Acinar cell carcinoma of the pancreas | Often used, by analogy with ductal cancer |
| Ampullary carcinoma | Some pancreatobiliary-type tumours |
Settings in pancreatic cancer
| Setting | Aim |
|---|---|
| After surgery (adjuvant) | Reduce the chance of the cancer returning |
| Before surgery (neoadjuvant) | Shrink borderline or locally advanced tumours so that surgery may become possible |
| Locally advanced, not removable | Control the cancer; sometimes followed by radiotherapy or surgery |
| Metastatic | Control the cancer, ease symptoms and extend life |
FOLFIRINOX before surgery
Some pancreatic cancers wrap around nearby blood vessels, making them difficult or impossible to remove straight away. Giving FOLFIRINOX first can shrink the tumour, treat any hidden spread and show how the cancer behaves.
If scans after several months show the cancer is stable or smaller, surgery may then be possible. The meta-analysis by Suker et al. (2016) found that, across the studies reporting it, about 28% of people with locally advanced cancer (91 of 325) went on to have their tumour removed after FOLFIRINOX.
Who is suitable
FOLFIRINOX is usually reserved for people with good performance status, meaning they are up and about and able to look after themselves. Doctors also check that bilirubin (a liver blood test) is normal or near normal, because irinotecan is cleared through the liver. People who are older or less fit may be offered other regimens or reduced doses.
4. Before treatment
| Step | Why it is done |
|---|---|
| Biopsy or confirmed diagnosis | Ensures the right treatment |
| CT scan | Staging and baseline for comparison |
| Blood tests | Blood counts, liver and kidney function, CA 19-9 tumour marker |
| Bile duct stent | Placed if jaundice is present, to bring bilirubin down |
| DPD testing | In many countries, a test for DPD deficiency, which makes fluorouracil dangerous |
| Central line | PICC or port for the pump |
| Pancreatic enzyme review | Many people need enzyme capsules to digest food |
| Dietitian review | Weight loss is common in pancreatic cancer |
DPD deficiency
A small number of people have reduced levels of an enzyme called DPD, which breaks down fluorouracil. In these people, standard doses can cause severe, sometimes life-threatening side effects. Testing beforehand allows the dose to be reduced or a different drug to be used.
5. What to expect: step by step
| Step | What happens |
|---|---|
| 1. Blood test | A day or two before each cycle |
| 2. Day 1 in the day unit | Anti-sickness medicines, then oxaliplatin, folinic acid and irinotecan over about 4-5 hours |
| 3. Pump connected | Fluorouracil pump attached before you go home |
| 4. Days 1-3 | Pump runs at home |
| 5. Day 3 | Pump disconnected at the hospital or by a community nurse |
| 6. Days 4-14 | Recovery; growth factor injections may be given |
| 7. Repeat | Next cycle on day 15 |
| 8. Scans | Usually every 2-3 months |
Tracking the tumour marker
Many pancreatic cancers release a protein called CA 19-9 into the blood. Measuring it every few cycles can give an early sign of how well treatment is working. It is not reliable for everyone, as some people do not produce it and high levels can also be caused by a blocked bile duct, so scans remain the main way of checking response.
Living with the pump
You can carry on with most daily activities while the pump is connected. Keep it dry when washing, sleep with it beside you, and follow instructions about what to do if it leaks or alarms. Most people find they adapt quickly.
6. Side effects and risks
| Side effect | Main cause | Notes |
|---|---|---|
| Tiredness | All | Very common; often builds with each cycle |
| Diarrhoea | Irinotecan, fluorouracil | Take loperamide as advised; seek help if severe |
| Early cramps, sweating and watery eyes | Irinotecan | During infusion; atropine helps |
| Nausea and vomiting | All | Anti-sickness medicines given routinely |
| Low blood counts and infection | All | Growth factor injections reduce the risk |
| Cold-triggered tingling | Oxaliplatin | Avoid cold drinks and touching cold objects for a few days |
| Numbness in hands and feet | Oxaliplatin | Builds over time; may lead to stopping oxaliplatin |
| Mouth sores | Fluorouracil | Mouth care and rinses |
| Hair thinning | Irinotecan | Usually partial |
| Sore hands and feet | Fluorouracil | Moisturise; report redness |
| Chest pain | Fluorouracil (rare) | Seek urgent help |
Managing nerve symptoms
Oxaliplatin causes two types of nerve problems. The first is a short-lived sensitivity to cold, with tingling in the hands, mouth or throat after each dose. The second is a build-up of numbness in the fingers and toes over many cycles. If numbness starts to affect everyday tasks, doctors often stop oxaliplatin and continue the other drugs.
7. Results and outlook
| Study | Main finding |
|---|---|
| PRODIGE 4/ACCORD 11, metastatic pancreatic cancer (342 people) | Median survival was 11.1 months with FOLFIRINOX versus 6.8 months with gemcitabine, and quality of life declined less often, although side effects were more frequent (Conroy et al., 2011) |
| PRODIGE 24, after surgery (493 people) | Modified FOLFIRINOX gave a median survival of 54.4 months compared with 35.0 months with gemcitabine, with more grade 3-4 side effects (Conroy et al., 2018) |
| Patient-level meta-analysis, locally advanced disease (315 people) | Median survival from the start of FOLFIRINOX was about 24 months across studies (Suker et al., 2016) |
What the evidence means
For fit people with pancreatic cancer, FOLFIRINOX offers the best results among chemotherapy options in several settings. The benefits come at the cost of more side effects, so careful monitoring and early dose adjustments are essential. Many people need dose reductions or delays during treatment, and this does not necessarily make it less effective.
8. Recovery and aftercare
Practical tips
| Tip | Why |
|---|---|
| Keep loperamide at home | Start it at the first loose stool, as advised |
| Drink plenty of fluids | Prevents dehydration from diarrhoea |
| Avoid cold for a few days after oxaliplatin | Reduces cold-triggered tingling |
| Check your temperature if unwell | Infection needs urgent treatment |
| Take enzyme capsules with meals | Helps absorption and weight |
| Keep moving | Gentle activity reduces tiredness |
Travelling during treatment
Short trips are often possible between cycles, but plan them around the days when your blood counts are lowest. Carry details of your treatment and the 24-hour helpline number, and check travel insurance covers cancer treatment. Ask your team before travelling abroad.
Nutrition
Weight loss is very common in pancreatic cancer and can make chemotherapy harder to tolerate. A dietitian can advise on high-energy foods, supplement drinks and pancreatic enzyme replacement. Even small improvements in nutrition can make a noticeable difference to strength and wellbeing.
Follow-up
During treatment, you will have blood tests before each cycle and scans every couple of months. After adjuvant treatment, follow-up usually includes regular clinic visits, CA 19-9 blood tests and scans.
When treatment is paused
In advanced disease, some people take a planned break from chemotherapy, or continue with fluorouracil alone, after several months of full FOLFIRINOX. This can give relief from side effects while keeping the cancer under control. Treatment is restarted or changed if the cancer grows.
Emotional support
A pancreatic cancer diagnosis can be overwhelming, and the treatment is intensive. Specialist nurses, pancreatic cancer charities and counsellors can help with information and coping. Many people find it helpful to talk about their priorities and what matters most to them during treatment.
9. Alternatives
| Alternative | When it is considered |
|---|---|
| Gemcitabine with nab-paclitaxel | Advanced pancreatic cancer; slightly less demanding |
| Gemcitabine with capecitabine | After surgery for people less suited to FOLFIRINOX |
| Gemcitabine alone | Less fit people |
| NALIRIFOX | An alternative combination for metastatic disease in some countries |
| Chemoradiotherapy or stereotactic radiotherapy | Some locally advanced cancers |
| Palliative radiotherapy | Pain relief, for example from coeliac plexus involvement |
| Clinical trials | New drugs and combinations |
10. Frequently asked questions
| Question | Answer |
|---|---|
| Will I lose my hair? | Thinning is common; complete loss is less common |
| Can I shower with the pump? | Keep the pump and line dry; use a waterproof cover |
| Can I work during treatment? | Some people can, often with adjusted hours |
| Why do cold drinks feel strange? | Oxaliplatin causes temporary cold sensitivity |
| Is the dose ever reduced? | Yes, frequently, to manage side effects |
| How long will I have treatment? | About 6 months after surgery; for advanced disease, as long as it helps |
| Will I need to stay in hospital? | Usually not; treatment is given in a day unit |
| Can I drink alcohol? | Small amounts may be fine; check with your team |
11. Questions to ask your care team
- What is the aim of FOLFIRINOX for me?
- Will I have the modified version?
- How many cycles are planned?
- Have I been tested for DPD deficiency?
- What should I do about diarrhoea or fever?
- Will I need pancreatic enzymes?
- What are the alternatives if I cannot tolerate it?
Resources
- Conroy, T. et al. (2011) ‘FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer’, New England Journal of Medicine, 364(19), pp. 1817-1825.
- Conroy, T. et al. (2018) ‘FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer’, New England Journal of Medicine, 379(25), pp. 2395-2406.
- Suker, M. et al. (2016) ‘FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis’, The Lancet Oncology, 17(6), pp. 801-810.
- National Cancer Institute (2026) Pancreatic Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/pancreatic/hp/pancreatic-treatment-pdq (Accessed: October 2026).
- National Cancer Institute (2026) FOLFIRINOX. Available at: https://www.cancer.gov/about-cancer/treatment/drugs/folfirinox (Accessed: October 2026).
Prepared by the editorial team, October 2026.